Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Cash Flow-to-Debt Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of CN¥1.84 Billion could theoretically repay 0% of its total liabilities (CN¥43.39 Billion) in one year. See Guangzhou Baiyunshan Pharmaceutical Hold leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Cash Flow-to-Debt Ratio (2000–2025)
Historical debt coverage capacity for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see 600332 cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Year-by-year debt coverage analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. Check Guangzhou Baiyunshan Pharmaceutical Hold cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | CN¥260.23 Million | CN¥43.39 Billion | ▼ -92.3% |
| 2024 | 0.08x | CN¥3.44 Billion | CN¥43.91 Billion | ▼ -19.9% |
| 2023 | 0.10x | CN¥4.10 Billion | CN¥41.91 Billion | ▼ -42.6% |
| 2022 | 0.17x | CN¥7.00 Billion | CN¥41.03 Billion | ▲ +4.6% |
| 2021 | 0.16x | CN¥5.67 Billion | CN¥34.79 Billion | ▲ +779.3% |
| 2020 | 0.02x | CN¥585.19 Million | CN¥31.55 Billion | ▼ -88.6% |
| 2019 | 0.16x | CN¥5.02 Billion | CN¥30.90 Billion | ▼ -11.7% |
| 2018 | 0.18x | CN¥5.22 Billion | CN¥28.34 Billion | ▼ -9.1% |
| 2017 | 0.20x | CN¥1.83 Billion | CN¥9.05 Billion | ▼ -31.7% |
| 2016 | 0.30x | CN¥2.44 Billion | CN¥8.24 Billion | ▲ +9.7% |
| 2015 | 0.27x | CN¥1.94 Billion | CN¥7.19 Billion | ▼ -4.1% |
| 2014 | 0.28x | CN¥1.76 Billion | CN¥6.25 Billion | ▲ +10.0% |
| 2013 | 0.26x | CN¥1.34 Billion | CN¥5.23 Billion | ▲ +1.7% |
| 2012 | 0.25x | CN¥506.53 Million | CN¥2.01 Billion | ▲ +233.7% |
| 2011 | -0.19x | CN¥-180.05 Million | CN¥956.09 Million | ▼ -314.9% |
| 2010 | 0.09x | CN¥73.17 Million | CN¥835.05 Million | ▼ -83.6% |
| 2009 | 0.54x | CN¥439.39 Million | CN¥820.92 Million | ▲ +7845.1% |
| 2008 | 0.01x | CN¥6.10 Million | CN¥905.99 Million | ▼ -94.8% |
| 2007 | 0.13x | CN¥375.74 Million | CN¥2.91 Billion | ▲ +714.6% |
| 2006 | 0.02x | CN¥38.88 Million | CN¥2.46 Billion | ▼ -75.2% |
| 2005 | 0.06x | CN¥146.32 Million | CN¥2.29 Billion | ▼ -18.9% |
| 2004 | 0.08x | CN¥200.54 Million | CN¥2.55 Billion | ▲ +2533.8% |
| 2003 | 0.00x | CN¥-6.83 Million | CN¥2.11 Billion | ▼ -103.4% |
| 2002 | 0.10x | CN¥169.01 Million | CN¥1.75 Billion | ▼ -2.6% |
| 2001 | 0.10x | CN¥140.15 Million | CN¥1.41 Billion | ▼ -45.9% |
| 2000 | 0.18x | CN¥286.95 Million | CN¥1.57 Billion | — |